SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marc H A Jansen, Reina W Kloet, Dannis G van Vuurden, Sophie EM van Zanten, Birgit I Witte, Serge Goldman, W Vandertop, Emile FI Comans, Otto S Hoekstra, Ronald Boellaard, Gert-Jan JL Kaspers, 18 F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma, EJNMMI Research, 2014, 4, 1, 8

    CrossRef

  2. 2
    Tarja S. Jokinen, Merja Haaparanta-Solin, Ranno Viitmaa, Tove J. Grönroos, Jarkko Johansson, Luciana Bergamasco, Marjatta Snellman, Liisa Metsähonkala, FDG-PET IN HEALTHY AND EPILEPTIC LAGOTTO ROMAGNOLO DOGS AND CHANGES IN BRAIN GLUCOSE UPTAKE WITH AGE, Veterinary Radiology & Ultrasound, 2014, 55, 3
  3. 3
    Olav B. Smeland, Tore W. Meisingset, Ursula Sonnewald, Dietary supplementation with acetyl-l-carnitine in seizure treatment of pentylenetetrazole kindled mice, Neurochemistry International, 2012, 61, 4, 444

    CrossRef

  4. 4
    S. Dupont, Imagerie fonctionnelle dans l’épilepsie, EMC - Neurologie, 2012, 9, 2, 1

    CrossRef

  5. 5
    Line V. Kristensen, Karin Sandager-Nielsen, Henrik H. Hansen, Kv7 (KCNQ) channel openers normalize central 2-deoxyglucose uptake in a mouse model of mania and increase prefrontal cortical and hippocampal serine-9 phosphorylation levels of GSK3β, Journal of Neurochemistry, 2012, 121, 3
  6. 6
    S. Dupont, Imagerie de l'épilepsie, EMC - Radiologie et imagerie médicale - Musculosquelettique - Neurologique - Maxillofaciale, 2010, 5, 3, 1

    CrossRef

  7. 7
    JH Kim, S Kim, S-I Suh, S-B Koh, K-W Park, K Oh, Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study, Cephalalgia, 2009, 29, 12
  8. 8
    Lara C. Foland, Lori L. Altshuler, Susan Y. Bookheimer, Naomi Eisenberger, Jennifer Townsend, Paul M. Thompson, Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania, Psychiatry Research: Neuroimaging, 2008, 162, 1, 27

    CrossRef

  9. 9
    Lori Altshuler, Susan Bookheimer, Jennifer Townsend, Manuel A Proenza, Fred Sabb, Jim Mintz, Mark S Cohen, Regional brain changes in bipolar I depression: a functional magnetic resonance imaging study, Bipolar Disorders, 2008, 10, 6
  10. 10
    Franck Semah, La TEP et la TEMP pour l’étude des épilepsies, Médecine Nucléaire, 2007, 31, 6, 329

    CrossRef

  11. 11
    Kimiaki Hashiguchi, Takato Morioka, Fumiaki Yoshida, Tadao Kawamura, Yasushi Miyagi, Yasuo Kuwabara, Masayuki Sasaki, Hirofumi Koga, Shinji Nagata, Tomio Sasaki, Thalamic hypometabolism on18FDG-positron emission tomography in medial temporal lobe epilepsy, Neurological Research, 2007, 29, 2, 215

    CrossRef

  12. 12
    Eun Yeon Joo, Seung Bong Hong, Woo Suk Tae, Sun Jung Han, Dae Won Seo, Kyung-Han Lee, Mann Hyung Lee, Effect of lamotrigine on cerebral blood flow in patients with idiopathic generalised epilepsy, European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33, 6, 724

    CrossRef

  13. 13
    Lori L. Altshuler, Susan Y. Bookheimer, Jennifer Townsend, Manuel A. Proenza, Naomi Eisenberger, Fred Sabb, Jim Mintz, Mark S. Cohen, Blunted Activation in Orbitofrontal Cortex During Mania: A Functional Magnetic Resonance Imaging Study, Biological Psychiatry, 2005, 58, 10, 763

    CrossRef

  14. 14
    Emily C. Bell, Morgan C. Willson, Alan H. Wilman, Sanjay Dave, Peter H. Silverstone, Differential effects of chronic lithium and valproate on brain activation in healthy volunteers, Human Psychopharmacology: Clinical and Experimental, 2005, 20, 6
  15. 15
    Bojana Stefanovic, Jan M. Warnking, Eliane Kobayashi, Andrew P. Bagshaw, Colin Hawco, François Dubeau, Jean Gotman, G. Bruce Pike, Hemodynamic and metabolic responses to activation, deactivation and epileptic discharges, NeuroImage, 2005, 28, 1, 205

    CrossRef

  16. 16
    Hei Yi Wong, Tsui Shan Chu, Janice Ching Lai, Kwok Pui Fung, Tai Fai Fok, Tatsuya Fujii, Yuan Yuan Ho, Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro, Journal of Cellular Biochemistry, 2005, 96, 4
  17. 17
    Csaba Juhász, Diane C. Chugani, Otto Muzik, Harry T. Chugani, Magnetic Resonance in Epilepsy, 2005,

    CrossRef

  18. 18
    Amanda E. Greene, Mariana T. Todorova, Thomas N. Seyfried, Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies, Journal of Neurochemistry, 2003, 86, 3
  19. 19
    Stephanie Krüger, David Seminowicz, Kim Goldapple, Sidney H Kennedy, Helen S Mayberg, State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge, Biological Psychiatry, 2003, 54, 11, 1274

    CrossRef

  20. 20
    A. Salek-Haddadi, K.J. Friston, L. Lemieux, D.R. Fish, Studying spontaneous EEG activity with fMRI, Brain Research Reviews, 2003, 43, 1, 110

    CrossRef

  21. 21
    Cecilie U. Johannessen, Svein I. Johannessen, Valproate: Past, Present, and Future, CNS Drug Reviews, 2003, 9, 2
  22. 22
    François Mauguière, Presurgical Assessment of the Epilepsies with Clinical Neurophysiology and Functional Imaging, 2003,

    CrossRef

  23. 23
    Todd D. Gould, Guang Chen, Husseini K. Manji, Mood stabilizer psychopharmacology, Clinical Neuroscience Research, 2002, 2, 3-4, 193

    CrossRef

  24. 24
    Amanda E. Greene, Mariana T. Todorova, Richard McGowan, Thomas N. Seyfried, Caloric Restriction Inhibits Seizure Susceptibility in Epileptic EL Mice by Reducing Blood Glucose, Epilepsia, 2001, 42, 11
  25. 25
    Cecilie U. Johannessen, Dirk Petersen, Frode Fonnum, Bjørnar Hassel, The acute effect of valproate on cerebral energy metabolism in mice, Epilepsy Research, 2001, 47, 3, 247

    CrossRef

  26. 26
    Masayuki Ide, Katsuyoshi Mizukami, Toshihito Suzuki, Hiroyasu Shiraishi, A case of temporal lobe epilepsy with improvement of clinical symptoms and single photon emission computed tomography findings after treatment with clonazepam, Psychiatry and Clinical Neurosciences, 2000, 54, 5
  27. 27
    John S. Duncan, Brain Mapping: The Disorders, 2000,

    CrossRef

  28. 28
    Eva Kumlien, Per Hartvig, Sven Valind, Ivar Øye, Joakim Tedroff, Bengt Långström, NMDA-Receptor Activity Visualized with (S)-[N-Methyl-11C]Ketamine and Positron Emission Tomography in Patients with Medial Temporal Lobe Epilepsy, Epilepsia, 1999, 40, 1
  29. 29
    M'hamed Bentourkia, Christian Michel, Gerard Ferriere, Anne Bol, Ann Coppens, Merence Sibomana, Raymond Bausart, Daniel Labar, Anne G. De Volder, Evolution of brain glucose metabolism with age in epileptic infants, children and adolescents, Brain and Development, 1998, 20, 7, 524

    CrossRef

  30. 30
    G. Capocchi, A. Balducci, M. Cecconi, M.A. Pelli, A. Picchiarelli, G. Silvestrelli, M. Zampolini, Valproate-induced epileptic tonic status, Seizure, 1998, 7, 3, 237

    CrossRef

  31. 31
    C. S. Brock, S. R. Meikle, P. Price, Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?, European Journal of Nuclear Medicine, 1997, 24, 6, 691

    CrossRef

  32. 32
    Juan P. Bolaños, JoséM. Medina, Effect of valproate on the metabolism of the central nervous system, Life Sciences, 1997, 60, 22, 1933

    CrossRef

  33. 33
    John S. Duncan, Positron Emission Tomography Studies of Cerebral Blood Flow and Glucose Metabolism, Epilepsia, 1997, 38,
  34. 34
    Rüdiger J. Seitz, Sabine Piel, Stephan Arnold, Gottfried Schlaug, Alois Ebner, Hans Holthausen, Ingrid Tuxhorn, Otto W. Witte, Cerebellar Hypometabolism in Focal Epilepsy Is Related to Age of Onset and Drug Intoxication, Epilepsia, 1996, 37, 12
  35. 35
    William D. Gaillard, Thomas Zeffiro, Shahin Fazilat, Charles DeCarli, William H. Theodore, Effect of Valproate on Cerebral Metabolism and Blood Flow: An 18F-2-Deoxyglusose and 15O Water Positron Emission Tomography Study, Epilepsia, 1996, 37, 6
  36. 36
    Thomas R. Henry, Functional Neuroimaging with Positron Emission Tomography, Epilepsia, 1996, 37, 12
  37. 37
    J. De Reuck, P. Santens, D. Decoo, L. Crevits, G. Van Maele, I. Lemahieu, K. Strijckmans, P. Goethals, Positron emission tomographic study of late-onset cryptogenic symptomatic seizures, Clinical Neurology and Neurosurgery, 1995, 97, 3, 208

    CrossRef

  38. 38
    R. Peyron, D. Le Bars, L. Cinotti, L. Garcia-Larrea, G. Galy, P. Landais, P. Millet, F. Lavenne, J.C. Froment, P. Krogsgaard-Larsen, F. Mauguie`re, Effects of GABAA receptors activation on brain glucose metabolism in normal subjects and temporal lobe epilepsy (TLE) patients. A positron emission tomography (PET) study Part I: Brain glucose metabolism is increased after GABAA receptors activation, Epilepsy Research, 1994, 19, 1, 45

    CrossRef

  39. 39
    Yasuyuki Futagi, Kazumasa Otani, Katsumi Imai, Reduction in Internal Carotid Arterial Blood Flow Velocity in Children During Antiepileptic Drug Therapy with Clinical Dosages, Epilepsia, 1994, 35, 4
  40. 40
    W.G. Sannita, V. Balestra, G. DiBon, K.M. Hassan, G. Rosadini, Ammonia-independent modifications of the background EEG signal and paradoxical enhancement of epileptic abnormalities in EEG after acute administration of valproate to epileptic patients, Neuropharmacology, 1993, 32, 9, 919

    CrossRef

  41. 41
    Pertti J. Rintahaka, Harry T. Chugani, Cristina Messa, Michael E. Phelps, Hemimegalencephaly: Evaluation with positron emission tomography, Pediatric Neurology, 1993, 9, 1, 21

    CrossRef

  42. 42
    Rochelle Caplan, Harry T. Chugairi, Cristina Messa, Donald Guthrie, Marian Sigtnan, Jean Traversay, Peter Mundy, HEMISPHERECTOMY FOR INTRACTABLE SEIZURES: PRESURGICAL CEREBRAL GLUCOSE METABOLISM AND POST- SURGICAL N0N-VERBAL COMMUNICATION, Developmental Medicine & Child Neurology, 1993, 35, 7
  43. 43
    References,